China Medical Universty Hospital
Taichung, 404, Taiwan
NCT Number: NCT01323894
The first year purpose:
The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.
Looking for future studies?
Notify Me10 year–80 year
All sexes
Observational
Taichung, 404, Taiwan
Our previous work is investigating the viral (Adv-BMP-2) administration for the development of a model to generate bones for possible use in clinical settings; the non-viral and viral administrations will be compared for best osteogenesis effects.
The first year purpose:
The best concentration of canonical Wnt3a will be investigated in promoting the osteoblastogenesis of human mesenchymal stem cells.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
August 2011-July 2013
China Medical University Hospital
Other
Osteogenic Effects in Human Mesenchymal Stem Cells Enhanced by Wnt Signaling/Hydroxyapatite Nanoparticles--Comparisons Between Non-viral and Viral Administration in Tissue Engineered Bone Regeneration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00552461
Lung Diseases, Primary Disease
Greenville, North Carolina, United States
View Trial DetailsNCT03702361
Primary Disease
Jerusalem, Please Select..., Israel
View Trial DetailsNCT01325194
Primary Disease
Aarhus, Denmark
View Trial DetailsNCT00803244
Primary Disease
Antony, France
View Trial Details